Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.90 (9.38%)
Spread: 1.00 (10.00%)
Open: 9.50
High: 10.50
Low: 9.50
Prev. Close: 9.60
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MicroSalt Operational Update

22 Mar 2023 07:00

RNS Number : 7791T
Tekcapital plc
22 March 2023
 

22 March 2023

Tekcapital Plc

("Tekcapital" or the "Group")

Portfolio Company Update: MicroSalt, Ltd. ("MicroSalt")

Operational Update

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to provide an operationalupdate from Microsalt Ltd ("Microsalt").

B2C Progress;

· SaltMe Crisps continue to be sold throughout the Kroger group. SaltMe Crisps are currently stocked in Kroger stores with efforts continuing to secure new store placements.

As announced on 13 March 2023, Hanahreum Group ("H Mart"), one of the fastest growing retailers in United States has agreed to carry MicroSalt's SaltMe® branded crisps.

Since launching in September 2022, MicroSalt Shakers are currently stocked in over 500 stores.

AS announced on 06 February 2023, MicroSalt is currently working with US Salt LLC for in store sales of products across the US Salt system. US Salt LLC is a leading direct supplier of canister salt to the US retail industry.

E-commerce progress;

First e-commerce sales of MicroSalt Shakers have been encouraging.

E-commerce sales of SaltMe Crisps have also been increasing.

Microsalt is preparing to launch its fourth flavour in a 1 oz size to compliment the current product offering and to create a better variety pack.

Medical Outreach campaign progress;

Direct outreach with free 1 oz shakers samples for the medical community.

Launched direct marketing campaign for shakers in March 2023 in partnership with the National Pancreas Foundation which includes access to approximately 100,000 medical professionals and 170 hospitals.

B2B progress:

· Successfully completed comprehensive testing of Microsalt with several major food companies. MicroSalt is at varying stages of progress with these company's respective tasting, procurement, marketing and packaging departments and will keep the market informed of further developments.

 

About MicroSalt, Ltd

MicroSalt, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving peoples' lives with better-for-you seasonings and snacks by taking the lead in the industry by providing the best low-sodium salt solution, based on the mechanical transformation of the salt particle itself. This solution is the only one that delivers real salt flavour because it is salt. Our new patented technology produces salt crystals that are approximately one hundred times smaller than typical table salt, delivering a powerful saltiness as the micro-grains dissolve in the mouth, with approximately 50% less sodium consumption. Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavour consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc. To learn more about MicroSalt please visit www.microsaltinc.com.

To learn more about SaltMe! snacks please visit www.saltme.com

 

Tekcapital owns 97% of the share capital of MicroSalt Ltd. and 6,034,683 shares (78%) of MicroSalt Inc., its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

 Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon

microsalt@flagstaffcomms.com

 

+44 (0)207 129 1474

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving MicroSalt and/or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of MicroSalt and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of MicroSalt or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither MicroSalt nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRANKDBPCBKDFNB
Date   Source Headline
1st Feb 20175:25 pmRNSHolding(s) in Company
31st Jan 20174:26 pmRNSTotal Voting Rights and Holding in Company
26th Jan 20173:00 pmRNSResults of proposed placing to raise £2.4m
26th Jan 20177:00 amRNSProposed placing
12th Jan 20177:00 amRNSNotice of Allowance for Energy Harvester Patent
4th Jan 20177:00 amRNSSuccessful Production and Testing of µSaltTM
28th Dec 20167:00 amRNSOut-licence & Strategic Alliance with Wecast
9th Nov 20167:00 amRNSDirectorate Change
31st Oct 20167:00 amRNSStrategic Alliance with Bajainnova SAPI de CV
28th Oct 20167:00 amRNSNotice of Allowance for 2nd Crackle-baked Patent
25th Oct 20167:00 amRNSPrivate Placement for Belluscura Ltd
7th Oct 20164:28 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSAcquisition of Medical Device Licence
31st Aug 20167:00 amRNSHalf-year Report
30th Jun 20167:30 amRNSGrant of Options
17th Jun 20167:00 amRNSPrivate Placement for Belluscura Ltd
6th Jun 201611:44 amRNSAcquisition of salt reduction technology patent
27th May 20162:47 pmRNSResult of AGM
4th May 20167:00 amRNSPosting of Annual Report and Notice of AGM
29th Apr 20167:00 amRNSFinal Results
28th Apr 20167:00 amRNSAcquisition and Total Voting Rights
20th Apr 201612:53 pmRNSHolding(s) in Company
13th Apr 20167:00 amRNSAcquisition of Medical Devices
14th Mar 20167:00 amRNSNew Technology License
12th Feb 20167:00 amRNSDirectorate Change
12th Jan 20167:00 amRNSTekcapital Chairman announced as award finalist
4th Jan 20163:06 pmRNSHolding(s) in Company
24th Dec 20157:00 amRNSAcquisition of Energy Harvesting Technology
22nd Dec 201512:52 pmRNSHolding(s) in Company
30th Nov 20155:30 pmRNSTotal Voting Rights
24th Nov 20152:14 pmRNSExercise of warrants and total voting rights
23rd Nov 20157:00 amRNSPatent Update for Crackle-baked(R) Technology
13th Nov 20159:15 amRNSHolding(s) in Company
10th Nov 20157:00 amRNSDirectorate Change
9th Nov 20157:00 amRNSNew Patent Application
9th Oct 20157:00 amRNSHolding(s) in Company
28th Aug 20155:00 pmRNSTotal Voting Rights
20th Aug 20157:00 amRNSHalf Yearly Report
14th Aug 20157:00 amRNSAcquisition of air conditioning efficiency patents
29th Jun 20157:00 amRNSAcquisition of energy harvesting technologies
22nd Jun 20154:27 pmRNSHolding(s) in Company
12th Jun 201511:52 amRNSResult of General Meeting
8th Jun 20157:00 amRNSGrant of Share Options
29th May 20156:15 pmRNSHolding(s) in Company
29th May 20156:15 pmRNSTotal Voting Rights
29th May 20151:13 pmRNSResult of AGM
21st May 201512:52 pmRNSFinal Results
14th May 20154:07 pmRNSHolding(s) in Company
13th May 20157:00 amRNSHolding(s) in Company
12th May 20152:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.